Next-Generation Solutions for mRNA Therapeutics: Advanced dsRNA Affinity Purification and Mass Photometry Characterization

Double-stranded RNA (dsRNA) impurities generated during in vitro transcription remain a critical challenge in mRNA therapeutic development, as they can trigger unwanted immune responses and are difficult to separate and characterize due to their similarity to target mRNA. In this webinar, experts from Refeyn and Repligen will present innovative purification and analytical technologies that enable highly selective dsRNA removal and sensitive single-molecule characterization, helping advance the safety, quality, and performance of mRNA-based therapeutics.